NO20070195L - Vaksine mot HPV16 og HPV18 og minst en annen HPV-type valgt fra HPV31, 45 eller 52 - Google Patents
Vaksine mot HPV16 og HPV18 og minst en annen HPV-type valgt fra HPV31, 45 eller 52Info
- Publication number
- NO20070195L NO20070195L NO20070195A NO20070195A NO20070195L NO 20070195 L NO20070195 L NO 20070195L NO 20070195 A NO20070195 A NO 20070195A NO 20070195 A NO20070195 A NO 20070195A NO 20070195 L NO20070195 L NO 20070195L
- Authority
- NO
- Norway
- Prior art keywords
- hpv31
- hpv18
- type selected
- vaccine against
- hpv type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413510.9A GB0413510D0 (en) | 2004-06-16 | 2004-06-16 | Vaccine |
US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
PCT/EP2005/006461 WO2005123125A1 (fr) | 2004-06-16 | 2005-06-14 | Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070195L true NO20070195L (no) | 2007-01-15 |
Family
ID=35160037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070195A NO20070195L (no) | 2004-06-16 | 2007-01-11 | Vaksine mot HPV16 og HPV18 og minst en annen HPV-type valgt fra HPV31, 45 eller 52 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1758609B1 (fr) |
JP (1) | JP2008502633A (fr) |
KR (1) | KR20070029254A (fr) |
AR (1) | AR049354A1 (fr) |
AU (1) | AU2005253723B2 (fr) |
BR (1) | BRPI0512042B8 (fr) |
CA (1) | CA2566620C (fr) |
FR (2) | FR15C0084I2 (fr) |
IL (1) | IL179138A0 (fr) |
LU (3) | LU92898I2 (fr) |
MA (1) | MA28692B1 (fr) |
MX (1) | MXPA06014515A (fr) |
NO (1) | NO20070195L (fr) |
PE (1) | PE20060434A1 (fr) |
PL (1) | PL1758609T3 (fr) |
RU (1) | RU2420313C2 (fr) |
SG (1) | SG153837A1 (fr) |
WO (1) | WO2005123125A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR053715A1 (es) * | 2005-04-26 | 2007-05-16 | Glaxosmithkline Biolog Sa | Vacuna multivalente de vph |
PT2318042E (pt) * | 2008-07-31 | 2014-11-05 | Glaxosmithkline Biolog Sa | Vacina contra hpv |
KR101181907B1 (ko) * | 2009-06-19 | 2012-09-11 | 아이진 주식회사 | 자궁경부암 백신 |
WO2012006727A1 (fr) * | 2010-07-15 | 2012-01-19 | British Columbia Cancer Agency Branch | Compositions d'antigène e7 du papillomavirus humain et leurs utilisations |
ES2608637T3 (es) | 2012-10-30 | 2017-04-12 | Pfizer Inc. | Vacunas basadas en partículas recombinantes contra la infección por el citomegalovirus humano |
EP3209676A4 (fr) * | 2014-10-24 | 2018-03-28 | Hpvvax, Llc | Traitement du cancer et de lésions cutanées |
CN107188966B (zh) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
US20060251676A1 (en) * | 2002-12-20 | 2006-11-09 | Gary Dubin | Hpv-16 and-18 l1 vlp vaccine |
-
2005
- 2005-06-14 PE PE2005000677A patent/PE20060434A1/es not_active Application Discontinuation
- 2005-06-14 WO PCT/EP2005/006461 patent/WO2005123125A1/fr active Application Filing
- 2005-06-14 AR ARP050102434A patent/AR049354A1/es not_active Application Discontinuation
- 2005-06-14 KR KR1020077001065A patent/KR20070029254A/ko active Application Filing
- 2005-06-14 EP EP05757953A patent/EP1758609B1/fr active Active
- 2005-06-14 RU RU2006143804/10A patent/RU2420313C2/ru active
- 2005-06-14 SG SG200904200-3A patent/SG153837A1/en unknown
- 2005-06-14 PL PL05757953T patent/PL1758609T3/pl unknown
- 2005-06-14 AU AU2005253723A patent/AU2005253723B2/en active Active
- 2005-06-14 JP JP2007515878A patent/JP2008502633A/ja active Pending
- 2005-06-14 BR BRPI0512042A patent/BRPI0512042B8/pt active IP Right Grant
- 2005-06-14 CA CA2566620A patent/CA2566620C/fr active Active
- 2005-06-14 MX MXPA06014515A patent/MXPA06014515A/es active IP Right Grant
-
2006
- 2006-11-09 IL IL179138A patent/IL179138A0/en unknown
- 2006-12-28 MA MA29576A patent/MA28692B1/fr unknown
-
2007
- 2007-01-11 NO NO20070195A patent/NO20070195L/no not_active Application Discontinuation
-
2015
- 2015-12-04 FR FR15C0084C patent/FR15C0084I2/fr active Active
- 2015-12-04 FR FR15C0082C patent/FR15C0082I2/fr active Active
- 2015-12-08 LU LU92898C patent/LU92898I2/fr unknown
- 2015-12-08 LU LU92900C patent/LU92900I2/fr unknown
- 2015-12-08 LU LU92899C patent/LU92899I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2566620C (fr) | 2014-03-11 |
KR20070029254A (ko) | 2007-03-13 |
AR049354A1 (es) | 2006-07-19 |
AU2005253723A1 (en) | 2005-12-29 |
BRPI0512042B1 (pt) | 2019-01-22 |
WO2005123125A1 (fr) | 2005-12-29 |
IL179138A0 (en) | 2007-03-08 |
FR15C0084I1 (fr) | 2016-01-08 |
EP1758609B1 (fr) | 2012-10-03 |
LU92900I2 (fr) | 2016-03-08 |
CA2566620A1 (fr) | 2005-12-29 |
FR15C0082I1 (fr) | 2016-01-08 |
AU2005253723B2 (en) | 2011-01-20 |
RU2006143804A (ru) | 2008-08-20 |
FR15C0084I2 (fr) | 2016-10-28 |
RU2420313C2 (ru) | 2011-06-10 |
PL1758609T3 (pl) | 2013-02-28 |
LU92899I2 (fr) | 2016-03-08 |
PE20060434A1 (es) | 2006-06-08 |
BRPI0512042A (pt) | 2008-02-06 |
FR15C0082I2 (fr) | 2016-10-28 |
JP2008502633A (ja) | 2008-01-31 |
MXPA06014515A (es) | 2007-03-23 |
BRPI0512042B8 (pt) | 2021-05-25 |
EP1758609A1 (fr) | 2007-03-07 |
SG153837A1 (en) | 2009-07-29 |
MA28692B1 (fr) | 2007-06-01 |
LU92898I2 (fr) | 2016-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070195L (no) | Vaksine mot HPV16 og HPV18 og minst en annen HPV-type valgt fra HPV31, 45 eller 52 | |
EP4215543A3 (fr) | Molécules de liaison spécifiques du vph | |
Stanley | Potential mechanisms for HPV vaccine-induced long-term protection | |
CR20200461A (es) | Método para tratar las enfermedades asociadas al vph | |
CY1111552T1 (el) | Χρηση hpv16 και hpv18 ως εμβολιο εναντι ενος ή περισσοτερων ογκογονικου hpv τυπου 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | |
Kim | Current status of cervical cancer and HPV infection in Korea | |
DK1296711T3 (da) | HPV-E7 til behandling af humant papillomavirus | |
MXPA02005639A (es) | Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico. | |
AR039005A1 (es) | Antigenos virales | |
EP1618889B8 (fr) | Vaccin contre l'influenza | |
WO2007121894A3 (fr) | Vaccin contre le papillomavirus à base de hpv-18 | |
ATE506063T1 (de) | Behandlung von hpv-induzierter intraepithelialer anogenitaler neoplasien | |
EP2065392A3 (fr) | Antigène de fusion utilisé en tant que vaccin | |
WO2007121895A3 (fr) | Vaccin contre le papillomavirus | |
CY1113830T1 (el) | Εμβολιο εναντι hpv16 και hpv18 και τουλαχιστον ενος αλλου τυπου hpv ο οποιος επιλεγεται απο hpv 31,45 ή 52 | |
NZ589755A (en) | Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same | |
WO2009042895A3 (fr) | Réactifs destinés à induire une réponse immunitaire | |
BR0209161A (pt) | Composição de vacina, kit de vacinação, método de tratamento médico, uso de um antìgeno de hpv, e, métodos para preparar uma vacina e para diminuir a transmissão viral do hiv | |
MX2022009964A (es) | Vacuna contra hpv. | |
Franceschi et al. | Human papillomavirus vaccines and anal carcinoma | |
ES533111A0 (es) | Un metodo de preparar una vacuna viva | |
NO20075194L (no) | vaksine | |
NZ516725A (en) | Use of modified HPV as a carrier for vaccine against cancer or viral infection of human papillomavirus | |
DE60236806D1 (de) | Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln | |
WO2004105681A3 (fr) | Epitopes du papillomavirus humain (hpv) cd4+ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |